Identification of Dihydroceramide Desaturase as a Directin VitroTarget for Fenretinide

Dihydroceramide desaturase activity is modulated by oxidative stress

(2010) Jolanta Idkowiak-Baldys et al.   BIOCHEMICAL JOURNAL

Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas

(2009) D Separovic et al.   BRITISH JOURNAL OF CANCER

Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells

(2009) Paola Signorelli et al.   CANCER LETTERS

Gastrosplenic Fistula From Hodgkin's Lymphoma

(2009) Carolyn D. Seib et al.   JOURNAL OF CLINICAL ONCOLOGY

Synthesis and Biological Activity of a Novel Inhibitor of Dihydroceramide Desaturase

(2008) Jose M. Munoz-Olaya et al.   ChemMedChem

The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis

(2008) Susanne Schiffmann et al.   JOURNAL OF LIPID RESEARCH

N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing

(2008) H. Wang et al.   MOLECULAR CANCER THERAPEUTICS

Principles of bioactive lipid signalling: lessons from sphingolipids

(2008) Yusuf A. Hannun et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY